A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G.
about
Crystal structure of the HSV-1 Fc receptor bound to Fc reveals a mechanism for antibody bipolar bridging.Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and ECharacterization of Antibody Bipolar Bridging Mediated by the Human Cytomegalovirus Fc Receptor gp68The herpes virus Fc receptor gE-gI mediates antibody bipolar bridging to clear viral antigens from the cell surfaceHepatitis C Virus Core Protein Discriminates Between the Two IgG2 AllotypesReplication of herpes simplex virus: egress of progeny virus at specialized cell membrane sites.The herpevac trial for women: Sequence analysis of glycoproteins from viruses obtained from infected subjects.Human cytomegalovirus Fcγ binding proteins gp34 and gp68 antagonize Fcγ receptors I, II and IIIIn vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor.Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivoExploitation of herpesviral transactivation allows quantitative reporter gene-based assessment of virus entry and neutralization.Complement Evasion Strategies of Viruses: An Overview.Herpes simplex virus type 1 glycoprotein E domains involved in virus spread and diseaseHuman cytomegalovirus open reading frame TRL11/IRL11 encodes an immunoglobulin G Fc-binding proteinHSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes.Herpes simplex virus type 2 glycoprotein E is required for efficient virus spread from epithelial cells to neurons and for targeting viral proteins from the neuron cell body into axons.Induction of immunoglobulin G Fc receptors by recombinant vaccinia viruses expressing glycoproteins E and I of herpes simplex virus type 1Herpes simplex virus type 1 evades the effects of antibody and complement in vivoRecombinant human cytomegalovirus (HCMV) RL13 binds human immunoglobulin G Fc.Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody.An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs.The herpes simplex virus 1 IgG fc receptor blocks antibody-mediated complement activation and antibody-dependent cellular cytotoxicity in vivo.Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compaGlycoproteins E and I facilitate neuron-to-neuron spread of herpes simplex virusCrucial genes and pathways in chicken germ stem cell differentiationImmune evasion properties of herpes simplex virus type 1 glycoprotein gC.Disulfide bond structure determination and biochemical analysis of glycoprotein C from herpes simplex virusImmune evasion by herpes simplex virus type 1, strategies for virus survivalIn vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gCThe human cytomegalovirus Fc receptor gp68 binds the Fc CH2-CH3 interface of immunoglobulin GHerpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells.Herpes simplex virus type 1 encodes two Fc receptors which have different binding characteristics for monomeric immunoglobulin G (IgG) and IgG complexesHerpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity.Roles of Us8A and Its Phosphorylation Mediated by Us3 in Herpes Simplex Virus 1 Pathogenesis.Immunization strategies to block the herpes simplex virus type 1 immunoglobulin G Fc receptor.Protection from lethal herpes simplex virus type 1 infection by vaccination with a UL41-deficient recombinant strain.Constitutive and Inducible Innate Responses in Cells Infected by HSV-1-Derived Amplicon Vectors.HSV Recombinant Vectors for Gene Therapy.Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor.
P2860
Q21092776-EC671F16-2C10-4D66-B9E8-11B92D995EFDQ24646778-B5844F1A-310A-4E0A-91DE-3AADB019E48CQ27320966-D5B3B835-AAF3-4D63-AF06-7504A7DDAD19Q27330259-2B588C6B-9CA0-4C0B-A771-DE34DD730C6DQ27488926-43C0CA38-5A10-4F38-BED6-817710354DAEQ30423181-7C6273CA-AD97-4F0C-9853-D984E9D0A98AQ33610941-2A5D9ADC-6459-479C-A918-967B56527521Q33618817-F8703D35-8830-4DC8-83D7-B8C72FA5C2FEQ33784845-A72E55A9-8CBE-4F5F-82C5-6E3E6BCB4EF3Q33784923-C5BCF21A-35C0-4A1D-BB5E-73E42A5423F9Q33802555-E9C851E4-FB2E-40C7-85A2-654ED210B732Q33804431-0A800507-B0E3-4794-931F-3C85C25824C9Q33808376-89DA1B2B-A26F-44E0-9D27-42BA40D2DC0BQ33849391-1B577779-3389-403A-9252-75A7C351D9D3Q33995747-49E1969C-190E-4061-ABF4-577F8D044418Q34057952-E7503E47-41C5-4F6C-8631-31C8EBD2A076Q34071917-EE873402-C47D-49A5-A740-49F8E344C2D5Q34185445-3F4B35DB-3214-43BE-A3F0-9500127B2527Q34345831-3DBB6E91-F9D3-4D14-A681-E28A94F5E2F9Q34505169-2D94C053-1478-490C-BF0C-C6123676EC43Q34545821-A7B6DE01-7BB4-4D71-9464-B90E5D3DCFF9Q34549656-02BDB160-57C8-4897-8849-EC2F2C7DC21CQ34742635-BAC024C4-63EF-44C2-95CF-C687E8A20079Q35275146-AE94BEA2-86B3-4CC5-A204-C9216A9B7DAFQ35851060-AF360826-7423-4B62-99F3-46F1D120027FQ35861049-6BF9191D-DD5D-4226-9A05-2870F868FA33Q35863299-F2062337-62BE-4568-BCDA-4ED610D53417Q35866354-E5D8E5F4-E3B8-41A9-9B42-C37776347395Q36372405-3FF665B9-E050-4248-A4E3-5CBDE39A0D72Q36375668-1A7617F4-4308-4EB5-8104-A4FE2C54135FQ36498191-A8761DEF-0BC2-4396-AD40-40565733C70DQ36626714-6FDFBB85-309B-496D-A097-7711804DF91AQ36807128-A1E814BA-245F-41CD-870F-F4138E087B89Q36829124-AF494EEC-B27C-4368-8868-68F7BBD5AFF2Q36950851-EE53F31D-C243-4B02-997A-8C9F14C068D3Q36955074-BFF5FEEA-6862-4467-8133-D8924773FBAFQ37460924-F956FC62-E732-41F4-8C33-205AB4E6A9E1Q37784704-32A602F5-F823-44F4-8E32-7CB21B97BF00Q37787777-64A16713-5809-4BE5-A091-B6E6047438AEQ38301851-9B7F3576-DF51-45EA-9825-6443B19D7BB3
P2860
A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
A novel function of the herpes ...... of antiviral immunoglobulin G.
@en
type
label
A novel function of the herpes ...... of antiviral immunoglobulin G.
@en
prefLabel
A novel function of the herpes ...... of antiviral immunoglobulin G.
@en
P2860
P1433
P1476
A novel function of the herpes ...... of antiviral immunoglobulin G.
@en
P2093
P2860
P304
P407
P577
1989-11-01T00:00:00Z